| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c8c98a38f38e8f0ca609b2b6540a82e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-085 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-085 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate |
2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95f83a14521582b19f833a43e4170755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed9c7492f021bd0a041f8d2a3982ef57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd4ba2ea82cbdf44223b8f529144d49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd5eec7e0595760b56643ec52fe81124 |
| publicationDate |
2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111518717-A |
| titleOfInvention |
A kind of Bacillus cereus and its inactivated vaccine and application |
| abstract |
The invention relates to the field of vaccinology, in particular to a Bacillus cereus and an inactivated vaccine and application thereof. Bacillus cereus SR52 is preserved in CCTCC, China Type Culture Collection Center, with the preservation number: CCTCC M 2019788 SR52, preservation date 2019.10.09, and the classification name is Bacillus wiedmannii. The application of the Bacillus cereus in the preparation of an immune inactivated vaccine against Bacillus cereus. The immune protection efficiency of the obtained inactivated vaccine against Bacillus cereus infection can reach more than 75%. The vaccine obtained by the invention has a simple preparation process, does not need extraction and purification, and has no potential safety hazard, and can achieve high-efficiency and long-term immune protection effects in one immunization. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113215017-A |
| priorityDate |
2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |